BRAF and primary biliary cholangitis: Median OS and rwPFS in the present BRAF-mutated PBC cohort are also generally similar to survival outcomes observed in clinical trials of first-line PBC in unselected aNSCLC patient populations (median OS = 7.9 mo, median PFS = 3.6 mo36).